Home :: Site Map :: Privacy Policy

Patient Advocate Foundation
Phone: (800) 532-5274
Fax: (757) 873-8999
Home > This Just In > PAF’s CPR Program Launches Lipodystrophy Disease Silo

CPR Launches Support for Patients Diagnosed with Lipodystrophy

The Co-Pay Relief program now offers funds to help patients afford treatment associated with the selective absence of fat from various parts of the body.

Hampton, VA, June 2, 2014 – Patient Advocate Foundation (PAF) announced today the expansion of its Co-Pay Relief (CPR) program with the opening of the Inherited or Acquired Lipodystrophy disease silo.   Patients diagnosed with a Lipodystrophy condition face localized or wide-spread loss of fat cells within their tissue, which can lead to severe metabolic complications and insulin resistance. Opened on June 2, 2014, this CPR program silo provides qualified  patients with financial grants of up to $10,000 towards their pharmaceutical co-payments. “This new fund will greatly help insured patients who are struggling to afford their medication costs associated with treatment and therapy related to their diagnosis of Lipodystrophy,” stated Fran Castellow, MSEd,  President of Operations for PAF and the Co-Pay Relief Program.

 “Insured patients typically face significant drug copayments and out of pocket costs that may prevent them from getting the treatment they need to combat this disease. We are confident these funds will allow more Lipodystrophy patients to access the medications they need,“ added Alan Balch,PhD, CEO of Patient Advocate Foundation. The Inherited or Acquired Lipodystrophy Silo is the first copayment assistance program in the country that addresses the high costs associated with an insured patient’s cost responsibility associated with treatment of this condition.  

To be eligible for support, patients must have an income of 400% or below the Federal Poverty limit and must be diagnosed with an inherited or acquired disorder. The CPR program provides qualified applicants  to this fund with up to $10,000 per year in grant support towards the required co-payments and co-insurance for the pharmaceutical treatments and therapies associated with their diagnosis of a Lipodystrophy.   To learn more or begin an application, patients can visit or call  a trained application specialist at 866-512-3861.

About Patient Advocate Foundation Co-Pay Relief Program
The Co-Pay Relief Program is an independent division of the nonprofit Patient Advocate Foundation (PAF), that celebrates its 10th year providing financial assistance to patients in 2014. A pioneer in the field of copayment support programs, PAF’s Co-Pay Relief program has provided more than $200 million in financial assistance to more than 155,000 patients who would have been otherwise unable to afford their pharmaceutical co-payments since 2004. Applications are accepted from insured patients who financially and medically qualify, including those covered by government sponsored insurance programs such as Medicare, Medicaid or Tricare. Keeping with PAF’s emphasis on patient-centric service, the program also offers individualized assistance to all patients through trained, professional staff who personally guide them through the enrollment process. For more information about PAF’s Co-Pay Relief program and the diseases in which support is available, visit or call 866-512-3861.